Isoflavones

estrogen receptor 2 ; Homo sapiens







38 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 28629129 Dietary Management of Skin Health: The Role of Genistein. 2017 Jun 17 1
2 27692995 Synthesis and structure-activity relationships of 1-benzylindane derivatives as selective agonists for estrogen receptor beta. 2016 Nov 15 1
3 26215320 Calycosin induces apoptosis by the regulation of ERβ/miR-17 signaling pathway in human colorectal cancer cells. 2015 Sep 1
4 26361015 The effect of glucuronidation on isoflavone induced estrogen receptor (ER)α and ERβ mediated coregulator interactions. 2015 Nov 2
5 22729816 Estrogen receptor-β gene polymorphism and colorectal cancer risk: effect modified by body mass index and isoflavone intake. 2013 Feb 15 2
6 24067281 Nuclear receptors - target molecules for isoflavones in cancer chemoprevention. 2013 Dec 1
7 22001128 Minimizing the cancer-promotional activity of cox-2 as a central strategy in cancer prevention. 2012 Jan 1
8 22799572 Growth inhibition of human thyroid carcinoma and goiter cells in vitro by the isoflavone derivative 7-(O)-carboxymethyl daidzein conjugated to N-t-boc-hexylenediamine. 2012 Aug 1
9 21160418 Additive effects of trastuzumab and genistein on human breast cancer cells. 2011 Mar 2
10 21161820 Estrogen receptor-β mediates the inhibition of DLD-1 human colon adenocarcinoma cells by soy isoflavones. 2011 6
11 21695893 [Changes of serum lipids after soy isoflavone and calcium supplementation in postmenopausal Chinese women with different ER-beta genotypes]. 2011 May 1
12 20110282 The chemopreventive action of equol enantiomers in a chemically induced animal model of breast cancer. 2010 May 1
13 20164315 Disposition of soy isoflavones in normal human breast tissue. 2010 Apr 1
14 20406033 The physiological actions of isoflavone phytoestrogens. 2010 1
15 20416510 A versatile microbial system for biosynthesis of novel polyphenols with altered estrogen receptor binding activity. 2010 Apr 23 1
16 20420908 Estrogenic properties of naturally occurring prenylated isoflavones in U2OS human osteosarcoma cells: Structure-activity relationships. 2010 Jun 2
17 19071129 Systemic administration of diarylpropionitrile (DPN) or phytoestrogens does not affect anxiety-related behaviors in gonadally intact male rats. 2009 Feb 1
18 19141699 Soy isoflavones modulate azoxymethane-induced rat colon carcinogenesis exposed pre- and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells by increasing the expression of estrogen receptor-beta. 2009 Mar 2
19 19298602 Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians. 2009 May 1
20 19393315 Multiple mechanisms of soy isoflavones against oxidative stress-induced endothelium injury. 2009 Jul 15 1
21 19480732 Soya isoflavone supplementation enhances spatial working memory in men. 2009 Nov 1
22 19776178 The pharmacokinetics of S-(-)equol administered as SE5-OH tablets to healthy postmenopausal women. 2009 Nov 1
23 18937077 Phytoestrogens induce differential estrogen receptor beta-mediated responses in transfected MG-63 cells. 2008 Aug-Dec 1
24 16441950 Does genotype and equol-production status affect response to isoflavones? Data from a pan-European study on the effects of isoflavones on cardiovascular risk markers in post-menopausal women. 2006 Feb 2
25 16513288 Isoflavones made simple - genistein's agonist activity for the beta-type estrogen receptor mediates their health benefits. 2006 2
26 16522905 Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. 2006 Mar 2
27 16972265 Signaling networks from Gbeta1 subunit to transcription factors and actin remodeling via a membrane-located ERbeta-related protein in the rapid action of daidzein in osteoblasts. 2006 Dec 1
28 16985246 Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings. 2006 Sep 20 4
29 15883431 S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. 2005 May 1
30 16099659 Isocoumarins as estrogen receptor beta selective ligands: Isomers of isoflavone phytoestrogens and their metabolites. 2005 Dec 1 2
31 16273360 Clinical significance of estrogen receptor beta in breast cancer. 2005 Nov 1
32 16332659 Soy-isoflavone-enriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol production. 2005 Dec 2
33 15544549 Cellular and physiological effects of soy flavonoids. 2004 Oct 1
34 12848640 Phytoestrogens increase the capacity of serum to stimulate prostacyclin release in human endothelial cells. 2003 Aug 1
35 11824555 Interaction of phytoestrogens with estrogen receptors alpha and beta (II). 2002 Jan 1
36 12468591 The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. 2002 Dec 1
37 11305594 Interaction of phytoestrogens with estrogen receptors alpha and beta. 2001 Apr 1
38 11522120 Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis. 2001 1